Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Apr. 29, 2022	Apr. 30, 2021	Apr. 24, 2020
Income Statement [Abstract]
Net sales	$ 31,686	$ 30,117	$ 28,913
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets	10,145	10,483	9,424
Research and development expense	2,746	2,493	2,331
Selling, general, and administrative expense	10,292	10,148	10,109
Amortization of intangible assets	1,733	1,783	1,756
Restructuring charges, net	60	293	118
Certain litigation charges	95	118	313
Other operating expense, net	862	315	71
Operating profit	5,752	4,484	4,791
Other non-operating income, net	(318)	(336)	(356)
Interest expense	553	925	1,092
Income before income taxes	5,517	3,895	4,055
Income tax provision (benefit)	456	265	(751)
Net income	5,062	3,630	4,806
Net income attributable to noncontrolling interests	(22)	(24)	(17)
Net income attributable to Medtronic	$ 5,039	$ 3,606	$ 4,789
Basic earnings per share (in dollars per share)	$ 3.75	$ 2.68	$ 3.57
Diluted earnings per share (in dollars per share)	$ 3.73	$ 2.66	$ 3.54
Basic weighted average shares outstanding (in shares)	1,342.4	1,344.9	1,340.7
Diluted weighted average shares outstanding (in shares)	1,351.4	1,354.0	1,351.1